Using advanced CRISPR to boost efficiency of CAR-T cell therapies
CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first ...
Tag: Acute Lymphoblastic Leukemia
CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma
CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear ...
Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias
Researchers from The University of Texas MD Anderson Cancer Center are presenting compelling findings from three clinical trials at the ...
Study finds no differences in CAR T-cell therapy outcomes among pediatric ALL patients across different socioeconomic levels
Social determinants of health affect the outcomes of many illnesses, and pediatric cancer is no exception. In fact, children with ...
Epigenetic changes prevent iron-associated programmed cell death in leukemia, research shows
The article, published in the journal Redox Biology by the group of Dr. Manel Esteller, shows that epigenetic changes prevent ...
New combination of drugs effective against T-cell acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is the most common cancer affecting children. The T-ALL form of leukemia that emerges from early ...
Adolescent and young adult leukemia survivors have reduced long-term survival compared to peers without cancer
Researchers at The College of Texas MD Anderson Cancer Middle have found that adolescent and young adult (AYA) cancer survivors ...
